FCG Investment Co Sells 20,777 Shares of Oscar Health, Inc. (NYSE:OSCR)

FCG Investment Co lessened its stake in Oscar Health, Inc. (NYSE:OSCR - Free Report) by 44.7% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 25,728 shares of the company's stock after selling 20,777 shares during the quarter. FCG Investment Co's holdings in Oscar Health were worth $346,000 as of its most recent filing with the SEC.

Several other large investors have also modified their holdings of OSCR. State Street Corp grew its position in shares of Oscar Health by 6.0% during the 3rd quarter. State Street Corp now owns 5,132,802 shares of the company's stock valued at $108,867,000 after buying an additional 291,335 shares during the last quarter. Nordea Investment Management AB bought a new position in shares of Oscar Health during the fourth quarter valued at approximately $1,056,000. Versor Investments LP bought a new stake in shares of Oscar Health in the 3rd quarter worth approximately $787,000. Janney Montgomery Scott LLC acquired a new position in Oscar Health during the 3rd quarter valued at approximately $988,000. Finally, Algert Global LLC grew its stake in Oscar Health by 63.3% during the 3rd quarter. Algert Global LLC now owns 369,685 shares of the company's stock worth $7,841,000 after buying an additional 143,346 shares during the last quarter. Institutional investors own 75.70% of the company's stock.

Insider Buying and Selling at Oscar Health

In related news, COO Steven Wolin sold 19,580 shares of Oscar Health stock in a transaction dated Monday, December 2nd. The stock was sold at an average price of $18.08, for a total transaction of $354,006.40. Following the sale, the chief operating officer now directly owns 102,598 shares of the company's stock, valued at $1,854,971.84. This trade represents a 16.03 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CAO Victoria Baltrus sold 8,078 shares of the business's stock in a transaction dated Monday, December 2nd. The shares were sold at an average price of $18.08, for a total value of $146,050.24. Following the transaction, the chief accounting officer now owns 146,036 shares in the company, valued at $2,640,330.88. This represents a 5.24 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have acquired 1,055,478 shares of company stock valued at $14,432,852 and have sold 103,610 shares valued at $1,847,519. Insiders own 25.11% of the company's stock.

Analyst Ratings Changes

OSCR has been the topic of a number of recent research reports. Jefferies Financial Group assumed coverage on Oscar Health in a research note on Tuesday, December 10th. They issued an "underperform" rating and a $12.00 target price on the stock. UBS Group assumed coverage on shares of Oscar Health in a research report on Monday, October 7th. They issued a "neutral" rating and a $23.00 price objective on the stock. Finally, Bank of America cut shares of Oscar Health from a "neutral" rating to an "underperform" rating and decreased their target price for the stock from $21.00 to $13.50 in a research report on Wednesday, November 6th. Two research analysts have rated the stock with a sell rating, two have assigned a hold rating, four have assigned a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, Oscar Health has a consensus rating of "Hold" and a consensus target price of $21.56.

Oscar Health Stock Up 1.3 %

NYSE OSCR traded up $0.22 on Friday, reaching $16.69. The stock had a trading volume of 3,264,974 shares, compared to its average volume of 3,122,218. Oscar Health, Inc. has a 1 year low of $11.52 and a 1 year high of $23.79. The business has a 50 day moving average price of $15.19 and a 200 day moving average price of $16.81. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.26. The company has a market capitalization of $4.13 billion, a price-to-earnings ratio of -278.12, a P/E/G ratio of 0.65 and a beta of 1.70.

Oscar Health (NYSE:OSCR - Get Free Report) last released its quarterly earnings results on Thursday, November 7th. The company reported ($0.22) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.20) by ($0.02). Oscar Health had a return on equity of 2.79% and a net margin of 0.35%. The company had revenue of $2.42 billion for the quarter, compared to the consensus estimate of $2.33 billion. During the same quarter last year, the company posted ($0.29) EPS. The business's revenue was up 68.3% compared to the same quarter last year. On average, analysts forecast that Oscar Health, Inc. will post -0.01 EPS for the current fiscal year.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.